Predicting & Avoiding Roadblocks in Drug Discovery Through CRO Partnering

Presented by The Blavanik Fund for Innovation at Yale

In drug discovery, you don’t know what you don’t know, until it is too late. Working with drug discovery CRO partners can anticipate many of the dead ends on the drug discovery map. Assay development, HTS screening, hit & lead optimization, PKPD, in vivo POC, formulation – hear our experts’ views on where the challenges lie and where new innovations can accelerate success.

Co-sponsored by Genesis
Genesis Biotechnology Group is a consortium of vertically integrated companies, with a mission of improving patient’s care through cross linking our expertise, dedication, and vision in the fields of drug discovery, personalized and tailored clinical diagnostics, and through the development, manufacturing and distribution of unique biotechnology-based products.

The event will begin at 4:30 and a light reception will follow.